Skip to main content
SpringerLink
Log in

Correlation Between Clinical Nodal Status and Sentinel Lymph Node Biopsy False Negative Rate After Neoadjuvant Chemotherapy

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Neoadjuvant chemotherapy (NAC) is the standard treatment for locally advanced breast cancer. It is now being used to treat operable breast cancer to facilitate breast-conserving surgery, but the accuracy of sentinel lymph node biopsy (SLNB) in breast cancer patients receiving NAC remains open to considerable debate.

Methods

We enrolled 96 patients with stage II–III breast cancer who received NAC from January 2001 to July 2010. All patients underwent breast surgery and SLNB, followed immediately by complete axillary lymph node dissection (ALND). Sentinel lymph nodes were detected with blue dye and radiocolloid injected intradermally just above the tumor and then evaluated with hematoxylin and eosin and immunohistochemical staining.

Results

The overall identification rate for SLNB was 87.5 % (84/96); the false negative rate (FNR) was 24.5 % (12/49); and the accuracy rate was 85.7 % (72/84). The FNR was significantly lower in clinically node-negative patients than in node-positive patients before NAC (5.5 % vs. 35.5 %; p = 0.001). Accuracy was also significantly higher in clinically node-negative patients than in node-positive patients before NAC (97.2 % vs. 77.1 %; p = 0.009). The FNR was 27.3 % among 46 clinically node-positive patients before NAC who were clinically node-negative after NAC. Among 12 patients with a complete tumor response (CR), the FNR was 0 %, compared with 26.1 % for 83 patients with a partial response and stable disease (p = 0.404).

Conclusions

Although associated with a high FNR after NAC, SLNB would have successfully replaced ALND in clinically node-negative patients before NAC and in patients with a CR after NAC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fisher B, Jeong JH, Anderson S et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567–575

    Article  PubMed  Google Scholar 

  2. Orr RK (1999) The impact of prophylactic axillary node dissection on breast cancer survival—a Bayesian meta-analysis. Ann Surg Oncol 6:109–116

    Article  PubMed  CAS  Google Scholar 

  3. Giuliano AE, Kirgan DM, Guenther JM et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398 discussion 398–401

    Article  PubMed  CAS  Google Scholar 

  4. Albertini JJ, Lyman GH, Cox C et al (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818–1822

    Article  PubMed  CAS  Google Scholar 

  5. Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672–2685

    PubMed  CAS  Google Scholar 

  6. Bonadonna G, Veronesi U, Brambilla C et al (1990) Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82:1539–1545

    Article  PubMed  CAS  Google Scholar 

  7. Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483–2493

    PubMed  CAS  Google Scholar 

  8. Fisher B, Mamounas EP (1995) Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol 13:537–540

    PubMed  CAS  Google Scholar 

  9. Kuerer HM, Newman LA (2005) Lymphatic mapping and sentinel lymph node biopsy for breast cancer: developments and resolving controversies. J Clin Oncol 23:1698–1705

    Article  PubMed  Google Scholar 

  10. Schwartz GF, Hortobagyi GN (2003) Committee CC proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast. April 26–28, 2003, Philadelphia, Pennsylvania. Cancer 100:2512–2532

    Article  Google Scholar 

  11. Sharkey FE, Addington SL, Fowler LJ et al (1996) Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 9:893–900

    PubMed  CAS  Google Scholar 

  12. Fisher ER, Wang J, Bryant J et al (2002) Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-18. Cancer 95:681–695

    Article  PubMed  Google Scholar 

  13. Mamounas EP, Brown A, Anderson S et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23:2694–2702

    Article  PubMed  Google Scholar 

  14. Xing Y, Foy M, Cox DD et al (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539–546

    Article  PubMed  CAS  Google Scholar 

  15. Kuerer HM, Sahin AA, Hunt KK et al (1999) Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230:72–78

    Article  PubMed  CAS  Google Scholar 

  16. Fraile M, Rull M, Julian FJ et al (2000) Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 11:701–705

    Article  PubMed  CAS  Google Scholar 

  17. Miltenburg DM, Miller C, Karamlou TB et al (1999) Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84:138–142

    Article  PubMed  CAS  Google Scholar 

  18. Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106:4–16

    Article  PubMed  Google Scholar 

  19. Le Bouedec G, Gauthier T, Gimbergues P et al (2008) Axillary recurrence after negative sentinel lymph node biopsy in breast cancer. Presse Med 37:1685–1687

    Article  PubMed  Google Scholar 

  20. Tausch C, Konstantiniuk P, Kugler F et al (2006) Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian sentinel node study Group. Ann Surg Oncol 15:3378–3383

    Article  Google Scholar 

  21. Shen J, Gilcrease MZ, Babiera GV et al (2007) Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109:1255–1263

    Article  PubMed  Google Scholar 

  22. Lee S, Kim EY, Kang SH et al (2007) Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat 102:283–288

    Article  PubMed  CAS  Google Scholar 

  23. Kinoshita T, Takasugi M, Iwamoto E et al (2006) Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Am J Surg 191:225–229

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research [C] (#21591677 MT).

Conflict of interest

The authors have no relevant conflict of interests.

Author information

Authors and Affiliations

  1. Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8587, Japan

    Maiko Takahashi, Hiromitsu Jinno, Tetsu Hayashida, Michio Sakata & Yuko Kitagawa

  2. Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan

    Keiko Asakura

Authors
  1. Maiko Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiromitsu Jinno
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tetsu Hayashida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michio Sakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keiko Asakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuko Kitagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiromitsu Jinno.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takahashi, M., Jinno, H., Hayashida, T. et al. Correlation Between Clinical Nodal Status and Sentinel Lymph Node Biopsy False Negative Rate After Neoadjuvant Chemotherapy. World J Surg 36, 2847–2852 (2012). https://doi.org/10.1007/s00268-012-1704-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-012-1704-z

Keywords

Search

Navigation